Fuan Pharmaceutical Group Co Strategic Asset Allocation Index
Fuan Pharmaceutical Group Co strategic asset allocation index. Fuan Pharmaceutical Group Co (300194) has a Strategic Asset Allocation Index of 42.0% as of June 2023. Strategic assets (PP&E of CN¥1.71 Billion plus long-term investments of CN¥-) total CN¥1.71 Billion, measured against net assets of CN¥4.07 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Fuan Pharmaceutical Group Co balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Fuan Pharmaceutical Group Co (2008–2021)
Strategic asset allocation index of Fuan Pharmaceutical Group Co from 2008 to 2021. This chart shows how Fuan Pharmaceutical Group Co's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 42.0%, representing strategic assets of CN¥1.71 Billion against net assets of CN¥4.07 Billion CNY. Check 300194 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Fuan Pharmaceutical Group Co Strategic Asset Allocation Index by Year (2008–2021)
Fuan Pharmaceutical Group Co strategic asset allocation index by year from 2008 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Fuan Pharmaceutical Group Co from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Fuan Pharmaceutical Group Co stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 37.4% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥3.87 Billion | ▲ +10.6 pp |
| 2020 | 26.8% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥4.56 Billion | ▼ -11.3 pp |
| 2019 | 38.1% | CN¥1.52 Billion | CN¥940.46 Million | CN¥579.84 Million | CN¥3.99 Billion | ▼ -0.8 pp |
| 2018 | 38.9% | CN¥1.44 Billion | CN¥943.23 Million | CN¥494.04 Million | CN¥3.69 Billion | ▲ +3.1 pp |
| 2017 | 35.8% | CN¥1.49 Billion | CN¥1.01 Billion | CN¥483.90 Million | CN¥4.17 Billion | ▼ -3.2 pp |
| 2016 | 39.0% | CN¥1.55 Billion | CN¥1.06 Billion | CN¥482.50 Million | CN¥3.96 Billion | ▲ +4.2 pp |
| 2015 | 34.8% | CN¥744.08 Million | CN¥744.08 Million | CN¥- | CN¥2.14 Billion | ▲ +3.6 pp |
| 2014 | 31.3% | CN¥534.04 Million | CN¥534.04 Million | CN¥- | CN¥1.71 Billion | ▼ -2.6 pp |
| 2013 | 33.9% | CN¥584.86 Million | CN¥584.86 Million | CN¥- | CN¥1.72 Billion | ▲ +9.1 pp |
| 2012 | 24.8% | CN¥426.15 Million | CN¥426.15 Million | CN¥- | CN¥1.72 Billion | ▲ +4.0 pp |
| 2011 | 20.7% | CN¥350.76 Million | CN¥350.76 Million | CN¥- | CN¥1.69 Billion | ▼ -34.7 pp |
| 2010 | 55.4% | CN¥155.69 Million | CN¥155.69 Million | CN¥- | CN¥281.05 Million | ▼ -17.0 pp |
| 2009 | 72.4% | CN¥118.25 Million | CN¥118.25 Million | CN¥- | CN¥163.31 Million | ▼ -9.5 pp |
| 2008 | 81.9% | CN¥90.73 Million | CN¥90.73 Million | CN¥- | CN¥110.76 Million | — |